The Egyptian Drug Authority (EDA) announced the conclusion of the specialized training program titled “Enhancing Medical Device Vigilance Performance Through ISO 9001 Standards.” The program aimed to support and strengthen the capacities of professionals working in the field of medical device vigilance and to improve regulatory performance efficiency through the practical application of the ISO 9001:2015 Quality Management System requirements, thereby contributing to enhanced safety and sustainable compliance.

The program featured a series of scientific and practical sessions that provided a comprehensive overview of the ISO 9001:2015 Quality Management System and its role in vigilance activities, while highlighting the benefits of implementing quality management systems and their direct impact on improving the performance of the medical device vigilance framework.

The program also included discussions on organizational context requirements, identification of interested parties, and analysis of internal and external issues affecting vigilance activities. In addition, it addressed defining the scope of the Quality Management System for vigilance activities, mechanisms for integrating ISO 9001 requirements into operational processes, leadership requirements and quality policy, the role of leadership in supporting vigilance activities, defining roles and responsibilities, and enhancing focus on service recipients.

Key topics further covered risk-based planning, setting quality objectives, managing change within the vigilance system, as well as support requirements, including capacity building, training systems, provision of resources and infrastructure, communication mechanisms, and control of documented information and records.

The program also reviewed operational aspects related to implementing the vigilance workflow cycle, controlling service provision, managing external service providers, and handling nonconformities. In addition, performance evaluation was discussed through monitoring key performance indicators, measuring stakeholder satisfaction, conducting internal audits and management reviews, and analyzing data to support decision-making.

The program concluded with a focus on continuous improvement, emphasizing corrective and preventive actions (CAPA) and root cause analysis (RCA). This was followed by a closing session titled “Integrating ISO 9001 Requirements into Vigilance Activities – From Strategy to Implementation,” during which practical steps for system implementation were presented, and an open discussion was held to address participants’ questions and inquiries.

This comes as part of the Egyptian Drug Authority’s ongoing efforts to enhance the efficiency of the medical device vigilance system and to implement quality management systems that ensure improved regulatory performance, increased medical device safety, and alignment with international best practices and standards.